Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 661

1.

Shp2 Inhibits Proliferation of Esophageal Squamous Cell Cancer via Dephosphorylation of Stat3.

Qi C, Han T, Tang H, Huang K, Min J, Li J, Ding X, Xu Z.

Int J Mol Sci. 2017 Jan 12;18(1). pii: E134. doi: 10.3390/ijms18010134.

2.

Inhibition of Src by microRNA-23b increases the cisplatin sensitivity of chondrosarcoma cells.

Huang K, Chen J, Yang MS, Tang YJ, Pan F.

Cancer Biomark. 2017;18(3):231-239. doi: 10.3233/CBM-160102.

PMID:
28085008
3.

Crucial role of carbonic anhydrase IX in tumorigenicity of xenotransplanted adult T-cell leukemia-derived cells.

Nasu K, Yamaguchi K, Takanashi T, Tamai K, Sato I, Ine S, Sasaki O, Satoh K, Tanaka N, Tanaka Y, Fukushima T, Harigae H, Sugamura K.

Cancer Sci. 2017 Mar;108(3):435-443. doi: 10.1111/cas.13163.

4.

A Novel NHERF1 Mutation in Human Breast Cancer and Effects on Malignant Progression.

Yang X, Du G, Yu Z, Si Y, Martin TA, He J, Cheng S, Jiang WG.

Anticancer Res. 2017 Jan;37(1):67-73.

PMID:
28011475
5.

IDH1/2 Mutation and MGMT Promoter Methylation - the Relevant Survival Predictors in Czech Patients with Brain Gliomas.

Kramář F, Minárik M, Benešová L, Halková T, Netuka D, Bradáč O, Beneš V.

Folia Biol (Praha). 2016;62(5):194-202.

6.

Promoter methylation attenuates SHP1 expression and function in patients with primary central nervous system lymphoma.

Liu J, Wang Y, Sun X, Ji N, Sun S, Wang Y, Liu F, Cui Q, Wang C, Liu Y.

Oncol Rep. 2017 Feb;37(2):887-894. doi: 10.3892/or.2016.5308. Epub 2016 Dec 8.

PMID:
27959415
7.

Suppression of bromodomain-containing protein 4 by shRNA: A new approach for cancer treatment.

Kaya T, Kahraman B, Bazarov N, Toker AS, Celik A, Cigdem S, Gunduz E.

Clin Invest Med. 2016 Dec 1;39(6):27493.

PMID:
27917784
8.

Epigenetic therapy approaches in non-small cell lung cancer: Update and perspectives.

Schiffmann I, Greve G, Jung M, Lübbert M.

Epigenetics. 2016 Dec;11(12):858-870. Epub 2016 Nov 15. Review.

PMID:
27846368
9.

Methylation status of homeobox genes in common human cancers.

Rodrigues MF, Esteves CM, Xavier FC, Nunes FD.

Genomics. 2016 Dec;108(5-6):185-193. doi: 10.1016/j.ygeno.2016.11.001. Epub 2016 Nov 5. Review.

PMID:
27826049
10.

ZNF143 enhances metastasis of gastric cancer by promoting the process of EMT through PI3K/AKT signaling pathway.

Wei S, Wang L, Zhang L, Li B, Li Z, Zhang Q, Wang J, Chen L, Sun G, Li Q, Xu H, Zhang D, Xu Z.

Tumour Biol. 2016 Sep;37(9):12813-12821. Epub 2016 Jul 23.

PMID:
27449034
11.

Protein phosphatase 4 catalytic subunit is overexpressed in glioma and promotes glioma cell proliferation and invasion.

Li M, Li X, Xu S, Xue P, Li Q, Lu Q, Jia Q, Zhang L, Li X, Li X.

Tumour Biol. 2016 Sep;37(9):11893-11901. Epub 2016 Apr 9.

PMID:
27059736
12.

Identification and characterization of PKF118-310 as a KDM4A inhibitor.

Franci G, Sarno F, Nebbioso A, Altucci L.

Epigenetics. 2017 Mar 4;12(3):198-205. doi: 10.1080/15592294.2016.1249089. Epub 2016 Oct 21.

PMID:
27767379
13.

NCYM is upregulated by lncUSMycN and modulates N-Myc expression.

Liu PY, Atmadibrata B, Mondal S, Tee AE, Liu T.

Int J Oncol. 2016 Dec;49(6):2464-2470. doi: 10.3892/ijo.2016.3730. Epub 2016 Oct 12.

PMID:
27748806
14.

Downregulation of HOTAIR Expression Mediated Anti-Metastatic Effect of Artesunate on Cervical Cancer by Inhibiting COX-2 Expression.

Zhang L, Qian H, Sha M, Luan Z, Lin M, Yuan D, Li X, Huang J, Ye L.

PLoS One. 2016 Oct 13;11(10):e0164838. doi: 10.1371/journal.pone.0164838. eCollection 2016.

15.

PlGF and VEGF-A Regulate Growth of High-Risk MYCN-Single Copy Neuroblastoma Xenografts via Different Mechanisms.

Zins K, Kovatchki D, Lucas T, Abraham D.

Int J Mol Sci. 2016 Sep 23;17(10). pii: E1613. doi: 10.3390/ijms17101613.

16.

SEPT9 and SHOX2 DNA methylation status and its utility in the diagnosis of colonic adenomas and colorectal adenocarcinomas.

Semaan A, van Ellen A, Meller S, Bergheim D, Branchi V, Lingohr P, Goltz D, Kalff JC, Kristiansen G, Matthaei H, Pantelis D, Dietrich D.

Clin Epigenetics. 2016 Sep 20;8:100. eCollection 2016.

17.

Bmi-1 promotes the invasion and migration of colon cancer stem cells through the downregulation of E-cadherin.

Zhang Z, Bu X, Chen H, Wang Q, Sha W.

Int J Mol Med. 2016 Oct;38(4):1199-207. doi: 10.3892/ijmm.2016.2730. Epub 2016 Sep 7.

18.

Expression of far upstream element binding protein 1 in B‑cell non‑Hodgkin lymphoma is correlated with tumor growth and cell‑adhesion mediated drug resistance.

Huang Y, Xu X, Ji L, Wang Y, Wang S, Tang J, Huang X, Yang X, He Y, He S, Cheng C.

Mol Med Rep. 2016 Oct;14(4):3759-68. doi: 10.3892/mmr.2016.5718. Epub 2016 Sep 6.

PMID:
27599538
19.

A biodistribution study of solid lipid-polyethyleneimine hybrid nanocarrier for cancer RNAi therapy.

Xue HY, Tran N, Wong HL.

Eur J Pharm Biopharm. 2016 Nov;108:68-75. doi: 10.1016/j.ejpb.2016.08.014. Epub 2016 Aug 26.

PMID:
27569032
20.

Hypoxic Proliferation of Osteosarcoma Cells Depends on Arginase II.

Setty BA, Jin Y, Houghton PJ, Yeager ND, Gross TG, Nelin LD.

Cell Physiol Biochem. 2016;39(2):802-13. doi: 10.1159/000447790. Epub 2016 Aug 1.

Supplemental Content

Loading ...
Support Center